Review
Published on 06 Jan 2022
Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.786913
- 8,537 views
- 11 citations
Type at least 3 characters
1,334 articles
Articles
Review
Published on 05 Jan 2022
Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.780655
- 12,448 views
- 20 citations
Correction
Published on 04 Jan 2022
Corrigendum: Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.796625
- 1,276 views
- 2 citations
Original Research
Published on 03 Jan 2022
Comprehensive Analysis of Immune Implication and Prognostic Value of IFI44L in Non-Small Cell Lung Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.798425
- 7,320 views
- 5 citations
Review
Published on 03 Jan 2022
Deciphering the Immune–Tumor Interplay During Early-Stage Lung Cancer Development via Single-Cell Technology
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.716042
- 5,399 views
- 6 citations
Case Report
Published on 03 Jan 2022
Camrelizumab-Related Myocarditis and Myositis With Myasthenia Gravis: A Case Report and Literature Review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.778185
- 4,055 views
- 13 citations
Original Research
Published on 03 Jan 2022
Downregulation of SLC27A6 by DNA Hypermethylation Promotes Proliferation but Suppresses Metastasis of Nasopharyngeal Carcinoma Through Modulating Lipid Metabolism
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.780410
- 3,971 views
- 15 citations
Original Research
Published on 24 Dec 2021
MiR-148b-3p Regulates the Expression of DTYMK to Drive Hepatocellular Carcinoma Cell Proliferation and Metastasis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.625566
- 2,346 views
- 7 citations
Case Report
Published on 24 Dec 2021
Case Report: Tumor Microenvironment Characteristics in a Patient With HER2 Mutant Lung Squamous Cell Carcinoma Harboring High PD-L1 Expression Who Presented Hyperprogressive Disease
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.760703
- 4,163 views
- 6 citations
Case Report
Published on 23 Dec 2021
Case Report: Sirolimus Alleviates Persistent Cytopenia After CD19 CAR-T-Cell Therapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.798352
- 4,213 views
- 8 citations
Correction
Published on 22 Dec 2021
Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.817747
- 1,232 views
Original Research
Published on 22 Dec 2021
A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.778637
- 4,018 views
- 3 citations
Original Research
Published on 16 Dec 2021
Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.786191
- 2,978 views
- 5 citations
Original Research
Published on 16 Dec 2021
Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.789078
- 4,526 views
- 12 citations
Original Research
Published on 13 Dec 2021
Different Glucose Metabolic Features According to Cancer and Immune Cells in the Tumor Microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.769393
- 4,513 views
- 8 citations
Original Research
Published on 10 Dec 2021
Clinical and Prognostic Significance of Tumor-Infiltrating CD8+ T Cells and PD-L1 Expression in Primary Gastrointestinal Stromal Tumors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.789915
- 3,318 views
- 13 citations